TABLE 2.
Organisms analyzed, range of number of isolates for which results were reported (varied year to year and drug to drug), and the drugs for which results were analyzed
| Organism | Institutions (range of isolates) | Drugs |
|---|---|---|
| E. cloacae | TJUH (220 to 238) | Ciprofloxacin, piperacillin-tazobactam, cefepime |
| E. coli | TJUH (1575 to 1748), MHD (631 to 763) | Ciprofloxacin, ceftriaxone, ampicillin |
| E. faecium | TJUH (204 to 213) | Ampicillin, linezolid, vancomycin |
| K. pneumoniae | TJUH (622 to 694), MHD (209 to 229) | Ciprofloxacin, piperacillin-tazobactam, ceftriaxone |
| MRSA | TJUH (301 to 318) | Clindamycin, erythromycin |
| MSSA | TJUH (462 to 530), MHD (173 to 196) | Clindamycin, erythromycin |
| P. aeruginosa | TJUH (516 to 896) | Cefepime, ciprofloxacin, piperacillin-tazobactam |
| P. mirabilis | TJUH (286 to 311) | Ceftriaxone, ciprofloxacin |
| S. epidermidis | TJUH (246 to 339) | Oxacillin, clindamycin |